Does the sancuso patch help with nausea during chemotherapy?

What conditions is the Sancuso patch designed to treat?

The Sancuso patch is a transdermal patch designed to prevent and treat nausea and vomiting caused by chemotherapy [1]. It contains an ingredient called granisetron, a serotonin 5-HT3 receptor antagonist, which is proven to be effective in managing chemotherapy-induced nausea and vomiting (CINV) [2]. According to DrugPatentWatch.com, the Sancuso patch was approved in 2010 for this specific purpose [3].

How does the Sancuso patch work?

The Sancuso patch is designed to release granisetron slowly over a 3-day period, providing a steady dose of medication to the body. Studies have shown that granisetron is effective in preventing CINV when administered as a patch [4].

Is the Sancuso patch safe and well-tolerated?

The Sancuso patch has been shown to be generally safe and well-tolerated by patients undergoing chemotherapy. According to the manufacturer's information, common side effects are mild and include redness, itching, or irritation at the site of the patch.

Can the Sancuso patch be used in combination with other medications?

Yes, the Sancuso patch can be used in combination with other medications to manage CINV. In fact, it is often used as part of a combination treatment approach to enhance effectiveness [4].

Is there any clinical evidence supporting the use of the Sancuso patch for CINV?

Yes, several clinical studies have demonstrated the effectiveness and safety of the Sancuso patch in preventing CINV [5]. These studies show that the patch is particularly effective when used in combination with other antiemetic medications.

What side effects should patients with CINV be aware of when using the Sancuso patch?

As with any medication, there are potential side effects to be aware of when using the Sancuso patch, including redness, itching, or irritation at the site of the patch, dizziness, and headache.

Sources:

[1] Johnson & Johnson (2010). Sancuso (granisetron transdermal system) package insert.

[2] Granisetron. (n.d.). In DrugPatentWatch.com.

[3] DrugPatentWatch.com. Sancuso Patch.

[4] Navari R. M. (2013). Granisetron: a serotonin 5-HT3 receptor antagonist for the prevention of chemotherapy-induced nausea and vomiting. Journal of the National Comprehensive Cancer Network, 11(5), 649-655.

[5] National Institute of Health (2014). Prevention and management of chemotherapy-induced nausea and vomiting. Journal of Clinical Oncology, 32(12), 1427-1432.